In 2018 an antidote was approved to reverse bleeding in people taking the newer blood thinners such as Apixaban (Eliquis) and Rivaroxaban (Xarelto). Unlike the older blood thinners such as warfarin that require frequent blood monitoring to prevent the risk of internal bleeding, the newer blood thinners are considered safer and don’t need monitoring.

And while these newer drugs may be considered a godsend for hospital management who can save a lot of money by avoiding blood tests, there is strong clinical evidence that these new blood thinners cause fatal internal bleeding.

The main problem with any blood thinner is that they increase the risk of internal bleeding. Blood thinners work by interfering with the clotting process that helps stop bleeding. But by doing so, they increase the risk of uncontrolled bleeding after an injury.

An increasing number of doctors are now calling for patients on new blood thinners to be monitored regularly to prevent the risk of internal bleeding. But this request will not be considered until the 10 years required to carry out a public drug trial expires.

And so those taking these new drugs must self-monitor themselves for signs of bleeding problems. You should look out for blotches on the skin that occur even with the slightest injury. There may also be prolonged or excessive bleeding after minor cuts, toothbrushing or shaving. When you observe such signs, it is imperative that you see your doctor and request a clotting profile to ensure all is well.

Dr Machi Mannu’s clinic MedB in Punta Prima serves the local community and patients who come from all over Europe for non-invasive diagnostics and science-based natural medicine.

To book a full-body scan call +34 865 616 862